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Abstract
Iodide efflux, an index of anion permeability, has been monitored in cultured rat brain endothelial cells. Following
hypotonicity-induced swelling, large, rapid increases in permeability occur, the extent of these increases depending on the
degree of hypotonicity. Such large responses are not observed with rat aortic endothelial cells. Results of anion substitution
experiments suggest that iodide efflux is via a chloride channel rather than an exchanger. The efflux increase is blocked by
 .NPPB 100 mM but not by DIDS or DPC at 100 mM. It is dependent on intracellular ATP but unaffected by removal of
external calcium. Increasing internal calcium using A23187 does not produce a change in efflux, but depletion of calcium
 .reduces or eliminates the response to hypotonicity. The response is reduced by pimozide 2–50 mM that inhibits the
 .actions of calmodulin and by pBPB 10 mM that affects phospholipase A activity. It is eliminated by 5-lipoxygenase2
 . inhibitors L-656,224 and ETH615, 10 mM but is unaffected by cyclo-oxygenase inhibitors indomethacin and piroxicam,
.  .  .1–100 mM . It is blocked by some modulators of P-glycoprotein activity, e.g., verapamil 100 mM , tamoxifen 50 mM ,
 .  .  .  .and progesterone 100 mM but not by others, e,g., forskolin 40 mM , dideoxyforskolin 40 mM , quinidine 100 mM and
 .cyclosporin A 10 mM .
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1. Introduction
The ability of capillary endothelial cells to regulate
their volume is a prerequisite for the preservation of
structural integrity of the blood-brain barrier. To
survive, all cells must avoid excessive alterations of
cell volume. The cellular content of osmolytes is
continuously changing in cells as a result of various
metabolic events including oxidative and detoxifica-
w xtion pathways 1 , and this is particularly so where
there is a constant through traffic of osmotically
active species such as amino acids and glucose.
Endothelial cells in most areas of the vasculature
form a permeable lining between blood and tissues
and so allow passage of materials between cells.
Brain endothelial cells are, however, different in that
they are attached to each other by tight junctions thus
forming a high resistance layer. This means that
materials crossing between blood and brain cannot
pass between cells but must pass through them. These
large fluxes of solutes expose brain endothelial cells
to the risk of large changes in their cellular contents
and hence volume. Efficient volume regulation is
therefore likely to be vital to the integrity of the
blood–brain barrier.
Cells can conveniently be caused to swell by a
rapid entry of water if they are shifted to a medium
of lower tonicity. The cells respond to this swelling
by a regulatory volume decrease, involving loss of
water secondary to loss of certain intracellular os-
molytes. In many cell types, this is achieved by exit
of Kq and Cly ions through swelling activated chan-
nels. There is no single common mechanism by
which this volume decrease occurs and different sig-
nalling pathways are involved in different cell types,
some being dependent on changes in intracellular
w xcalcium while others are calcium independent 2,3 .
Chloride channels involved in regulatory volume
decrease have been identified in various endothelial
cell types including those derived from bovine pul-
monary artery, human aorta and human umbilical
w xvein 4 , but rather few studies have involved en-
dothelial cells derived from brain microvasculature
w x5 . In the present study, we investigate the properties
of volume-sensitive chloride channels in cultured rat
brain endothelial cells and the possible intracellular
signalling pathways involved in their activation using
the iodide efflux technique as a measure of anion
permeability. Iodide is a suitable marker for chloride
movement since it shows similar conductive perme-
ability to chloride but is a relatively poor substrate
w xfor cotransport pathways 6 . We demonstrate here
that the increased iodide efflux in response to hypo-
tonicity is relatively insensitive to DIDS and to ma-
noeuvres designed to perturb intracellular calcium.
The iodide efflux is also insensitive to blockade of
cyclooxygenase but is markedly reduced by inhibitors
of phospholipase A and 5-lipoxygenase.2
Brain microvascular endothelial cells unlike those
of the aorta or other large vessels express P-glyco-
w xprotein 7 , a protein that in some studies has been
w xassociated with volume regulatory pathways 8 . We
show here that the hypotonicity-induced anion per-
meability changes in the brain endothelial cells are
sensitive to some but not all agents that inhibit the
function of P-glycoprotein. Whether P-glycoprotein
is involved in modulating the permeability changes in
brain endothelial cells is not clear but aortic endothe-
lial cells not expressing P-glycoprotein show smaller
increases in iodide permeability in response to hypo-
tonicity.
Preliminary results of this work have already been
w xpublished in abstract form 9 . Further characterisa-
tion of the channels involved in this response has
been undertaken using whole cell patch clamp record-
ings and preliminary results of this work have already
w xbeen reported in brief 10 .
2. Materials and methods
2.1. Cell culture
Brain microvessels were isolated from cortical grey
w xmatter of rats as previously described 7 and either
used immediately for cell culture or stored frozen in
liquid nitrogen in medium containing 10% DMSO for
 .later culture. Brain endothelial cells BECs were
grown from these microvessels in collagen-coated
culture flasks in Hams F10 medium containing 20%
plasma-derived serum, 75 mgrml endothelial cell
growth supplement First Link, Brierley Hill, West
.Midlands, UK , 80 mgrml heparin, 0.5 mgrml vita-
min C, 2 mM L-glutamine, 100 Urml penicillin and
100 mgrml streptomycin. The cells were used for the
iodide efflux experiments after 1–5 passages. At the
( )S.F. ˝on Weikersthal et al.rBiochimica et Biophysica Acta 1325 1997 99–107 101
later passages, fetal calf serum was often used in
place of plasma-derived serum in the medium to
encourage growth of the endothelial cells without
fear of overgrowth by contaminating cells that may
be present in the earliest passages. Aortic endothelial
 . cells AECs kindly supplied by Ms. Heather Lauder
in the Department of Pharmacology, University of
.Cambridge, UK were cultured from aortic rings
taken from the rats. These were maintained in the
same medium as for the BECs but did not require
collagen-coated surfaces on which to grow.
2.2. Iodide efflux experiments
Cells were plated into 12-well plates at a density
of 105 cellsrwell 3 days before the experiments. All
stages of the experiments were performed at 378C.
Efflux measurements were performed as previously
w xdescribed 11 . Briefly cells were loaded with 92.5
kBq mly1 125Iy in efflux solution for 90 min and
subsequently washed three times with 1 ml of efflux
solution to remove extracellular tracer. Samples for
determination of 125Iy efflux were then obtained each
40 s by completely removing the efflux solution and
replacing it with 1 ml of fresh efflux solution. At the
end of the collections, the 125Iy remaining in the cells
was extracted by digesting the cells with 1 ml of 0.1
M HNO for 30 min. The samples were transferred3
to a g-counter for measurement of 125Iy.
When given, the hypotonic stimulus was applied
by substituting the isotonic efflux solution for the
hypotonic solution at the 4 min time-point. This
hypotonic solution was then used throughout the rest
of the experiment. Where drug effects were being
examined, the drug was added to the 125Iy solution
during the last 30 min of loading and was present in
the isotonic and hypotonic efflux solutions used
thereafter. When chloride was replaced with glu-
conate, the cells were loaded with 125Iy in chloride
containing solutions and the gluconate solution was
used for the washes and efflux periods. In an individ-
ual experiment each condition was examined in tripli-
 .cate sometimes sextuplicate and three or more wells
were used for controls. Values of n refer to the
number of wells counted for that condition. Data for
each substance were obtained on at least two separate
occasions unless indicated. Whenever a stimulated
increase in rate constant is expressed as a percentage
Fig. 1. Effects of different levels of hypotonic challenge on
 .increases in rate constant for iodide efflux from a rat brain
 .endothelial cells and from b rat aortic endothelial cells. Solu-
tions were changed at the 4 min time-point from isotonic contain-
ing 90 mM mannitol to hypotonic in which mannitol concentra-
 .  .tions were decreased by 90 mM v , 60 mM I , or 30 mM
 .  .B . In the controls the replacement solution was isotonic ‘ .
Values shown at each time point are the mean"S.E. of samples
from three separate wells.
of control, the control value is the mean of the
stimulated increase in the control wells from the
same experiment. Numerical values are stated as
mean"standard deviation. The values plotted in Fig.
1 and Fig. 2 are mean"S.E.
2.3. Data processing and analysis
The rate constant for efflux was calculated sepa-
rately from the efflux data for each well as follows.
Fig. 2. Effects of replacement of chloride by gluconate and of
NPPB on the increases in rate constant for iodide efflux from rat
brain endothelial cells. Solutions were changed at the 4 min time
point from isotonic containing 90 mM mannitol to hypotonic in
 .  .which the mannitol was omitted. B Control response; I
response using iso- and hypotonic solutions containing gluconate
 .  .instead of chloride; ‘ response chloride solutions with 100
mM NPPB present throughout. Values shown at each time point
are the mean"S.E. of samples from three separate wells.
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The total counts in a batch of cells before the sample
at time 0 was first calculated by adding together the
counts above background in all the samples including
the counts removed from the cells using nitric acid.
The counts remaining in the cells after each sample
were then found by successively subtracting the
counts above background collected in each sample.
The rate constant at the time of the sample was then
calculated as
rate constant
s 1rtime interval .
counts remaining after previous sample
= ln  /counts remaining after sample
Loading of the cells was characterized by the number
of counts in the cells 160 s after the sample at time 0
i.e., the sum of the counts in all samples starting
with the fifth and including the counts removed using
.nitric acid .
2.4. Solutions and chemicals
Compositions of the solutions were as follows: the
isotonic solution measured osmolality of 288
.  .mOsmol contained mM : NaCl 87, KCl 4, MgSO4
0.6, CaCl 0.3, KH PO 0.6, Na HPO 1.1, Hepes2 2 4 2 4
10, mannitol 90 and glucose 6 pH adjusted to 7.4
.with NaOH . The hypotonic solutions were the same
but with mannitol reduced or absent. i.e., 60, 30, and
0 mM respectively producing solutions of measured
.osmolality of 259, 228 and 197 mOsmol . In some
early experiments, instead of 10 mM Hepes the solu-
tions were buffered with 14 mM NaHCO and bub-3
bled with 95% O r5% CO . No differences were2 2
observed between the responses obtained with the
two buffers. Unless otherwise stated, all compounds
and media were either standard analytical grade
 .reagents or were obtained from Sigma Poole, UK .
NPPB was obtained from Research Biochemicals
International, Natick, MA, dtBHQ from Aldrich,
Poole, UK, and A23187 from Calbiochem Nova-
biochem, Nottingham, UK. Cyclosporin A was a gift
of Ms. K. Wright, MRC Centre, Cambridge, UK,
ETH615 was a gift of Dr. E. Petersen, Leo Pharma-
ceuticals, Ballerup, Denmark, and L-656,224 was a
gift of Dr. A.W. Ford-Hutchinson, Merck Frosst
Canada, Pointe-Claire-Dorval, Quebec. Sodium glu-
conate was prepared from gluconic acid Aldrich,
.Poole, UK and sodium hydroxide.
3. Results
The amount of 125Iy loaded into the rat brain
endothelial cells varied with the number of cells but
was typically 2000 counts miny1 welly1. At the tracer
levels used in these experiments, iodide is always at a
 .very low concentration -10 nM and the rate con-
stant for efflux should be independent of the loading.
The basal rate constant for efflux was typically 0.15
to 0.3 miny1.
Following the maximum hypotonic challenge, io-
dide efflux from brain endothelial cells increased
rapidly from basal values to reach a peak 0.98"0.37
y1 .min , mean"S.D., ns243 within 40–80 s. As
shown in Fig. 1, the magnitude of the peak increase
in iodide efflux was dependent on the level of hypo-
tonicity and clear responses were seen even for re-
ductions in osmolality as small as by reduction of the
mannitol concentration by 30 mM. By contrast see
.inset, Fig. 1b even with a reduction in mannitol
concentration of 90 mM only small peak responses
 y1 .0.37"0.29 min at peak, mean"S.D., ns19
were seen with endothelial cells from rat aorta.
A peak rate constant of 1.3 miny1 corresponds to a
loss within 40 s of 60% of the iodide present at the
start of the sample period. Given this rapid loss, tests
were undertaken to determine whether the hypotonic-
ity challenge might lead to a general increase in cell
membrane permeability. For this purpose, cells were
w3 x 125 y loaded with H vincristine instead of I 30 nM
.solution for 90 min and then exposed for 10-min
periods firstly to isotonic buffer, then to hypotonic
 .buffer without mannitol and then to water alone.
After each exposure the buffer surrounding the cells
was collected and assessed for its radioactive content.
There was no difference in the rate constant for
w3 xH vincristine efflux into isotonic or hypotonic buffer
but there was a large and rapid efflux following
 .exposure to water alone data not shown . Likewise,
when the basal release of ATP was monitored, no
difference was found between isotonic and hypotonic
buffer exposure. Only when the cells were exposed to
water a large release of ATP was observed Barrand
.and Kennedy, unpublished observations .
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Table 1
Effect of inhibition of enzymes in the arachidonic acid metabolic
pathway, phospholipase A , lipoxygenase and cyclooxygenase,2
on hypotonicity-induced iodide efflux from rat brain endothelial
cells
Concentration Response remaining as a
percentage of control
 .mean"S.D. n
 .Pimozide 2 mM 38" 8 3
 .10 mM 18"12 3
 .50 mM 9"18 6
 .pBPB 10 mM 15"20 9
 .ETH615 1 mM 100" 9 3
 .10 mM 1" 5 9
 .L-656,224 10 mM 1"11 9
 .Indomethacin 1 mM 98" 6 3
 .10 mM 101" 6 3
 .100 mM 90"16 3
 .Piroxicam 1 mM 125"17 3
 .10 mM 105"20 3
 .100 mM 87"38 6
Inhibitors were present during the last 30 min of iodide loading
and throughout the efflux period. Efflux was stimulated by
changing from isotonic solution containing 90 mM mannitol to
hypotonic solution in which the mannitol had been omitted.
Responses with and without the inhibitory agents are compared at
the peak increase in rate constant for efflux. None means that no
increase in iodide efflux could be seen in the presence of the
inhibitor.
The decrease in the efflux rate constant after the
peak may be a consequence of regulatory volume
decrease which would remove the stimulus to in-
creased anion permeability. However, further evi-
dence is required before reaching this conclusion
w x11 . A similar decrease in the rate constant would be
seen if the iodide loaded into two distinct kinetic
compartments: a large compartment, perhaps cyto-
plasm, in which the iodide is available for rapid
stimulated efflux and a small compartment, perhaps
intracellular organelles, in which it is not. The calcu-
lated rate constant would then decrease as the tracer
was depleted from the large compartment.
Evidence that the iodide efflux occurs through ion
channels rather than by exchange for extracellular
chloride was obtained by replacing the chloride in the
external medium with gluconate. Gluconate is a poor
substrate for exchange. Thus if efflux were to occur
via this mechanism the substitution should substan-
tially reduce the rate. As shown in Fig. 2, this did not
happen which suggests that the efflux occurs via ion
channels. The driving force for efflux by this mecha-
nism is expected to be maintained as the intracellular
potential will be kept negative by efflux of potas-
sium. In three experiments with gluconate the in-
crease in the rate constant as a percentage of the
increase seen in the chloride controls was 128"44%,
mean"S.D., ns9. Further evidence for efflux via
channels rather than exchange was obtained using
whole-cell patch clamp experiments in which a
marked increase in chloride conductance occurs when
w xthese cells are exposed to hypotonic solutions 10 .
The efflux was however relatively insensitive to chlo-
ride channel inhibitors. While a high concentration of
NPPB did reduce the response the same concentra-
tion of DIDS and DPC produced little if any inhibi-
tion. As a percentage of the increase seen in the
controls the increase in the rate constants for efflux in
the presence of the inhibitors were: NPPB 100 mM
 .Fig. 3. Effects of a the lipoxygenase inhibitor, ETH615 at 10
 .mM, and b the cyclooxygenase inhibitor, indomethacin at 100
mM on the rate constant for iodide efflux from rat brain endothe-
lial cells. Solutions were changed at the 4 min time-point from
isotonic, i.e., containing 90 mM mannitol, to hypotonic, i.e., with
90 mM mannitol omitted. Control responses in the absence of
inhibitors are shown as closed symbols, test responses in the
presence of the inhibitors as open symbols. In the test experi-
ments, inhibitors were present during the last 30 min of loading
with iodide and throughout the subsequent efflux period. Values
shown at each time point are the mean"S.E. of samples from
three separate wells.
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 . 14"17% ns6 , DIDS 100 mM 91"12% ns
.  .  .12 ; and DPC 104"27% ns6 one experiment .
Depletion of intracellular ATP by replacement of
glucose by 6 mM deoxyglucose and addition of 10
mM sodium azide to both loading and efflux solu-
 .tions always completely blocked the response ns9 .
When depletion was started only at the time of the
washes i.e., 5 min before the change to hypotonic
.solution the response was completely eliminated in
 . two experiments ns6 and reduced 77"60%,
.ns3 in a third. These results are consistent with
other reports that the increased anion permeability
requires internal ATP.
The possible involvement of calcium in the iodide
efflux response was investigated. Firstly removal of
extracellular calcium by using calcium free solution
containing 1 mM EGTA during the washes and ef-
flux period did not block the increase in iodide
 .permeability 108 " 54%, mean " S.D., n s 12 .
Secondly to determine the importance of intracellular
calcium, cells were preincubated with thapsigargin at
 .a concentration 1 mM which is usually sufficient to
block uptake of calcium into intracellular stores. This
together with calcium-free solution containing 1 mM
EGTA produced variable effects on the hypotonic
 .response, with apparently no effect one experiment ,
a delay of the response by about 1.5 min one
.  .experiment , reduction to 73% one experiment , and
 .complete abolition of response one experiment . A
higher concentration of thapsigargin, 10 mM, abol-
 .ished the response one experiment . Other methods
used to deplete intracellular calcium caused incom-
plete inhibition of the response: 100 mM dtBHQ, an
alternative to thapsigargin for blocking the calcium
pump of intracellular stores, reduced the response to
 .24"6% ns3 and the ionophore, A23187, used at
1 mM in calcium free solution containing 1mM
 .EGTA reduced it to 43"6% ns3 . Finally to test
whether an increase in internal calcium can trigger a
response, cells suspended in the normal calcium-con-
taining isotonic solution were exposed to 1 mM
A23187 instead of hypotonic solution at the 4 min
time-point during the efflux period. This produced no
significant increase in iodide efflux compared to con-
trols exposed to hypotonic solution -5"10%, ns
.6 .
The involvement of arachidonic acid or its metabo-
lites in the control of the stimulated anion efflux from
brain endothelial cells was investigated using in-
hibitors of calmodulin, phospholipase A , cyclooxy-2
 .genase and 5-lipoxygenase see Table 1 and Fig. 3 .
Pimozide, a calmodulin inhibitor, produced greater
 .than 50% inhibition even at 2 mM ns3 and
 .completely eliminated responses at 50 mM ns6 .
Similarly the phospholipase A inhibitor pBPB 102
.mM eliminated or reduced the efflux. Neither indo-
Table 2
Effect of resistance modifiers, i.e., agents that inhibit P-glycoprotein mediated drug efflux from rat brain endothelial cells
Agent Concentration Response remaining as a
applied percentage of control
 .mean"S.D. n
 .  .Verapamil 3–10 mM 50 mM 74" 8 6
 .100 mM 11"16 18
 .  .Dideoxyforskolin 40 mM 40 mM 97"12 9
 .  .Cyclosporin A 2 mM 10 mM 98"20 3, 1 exp.
 .  .Forskolin 40 mM 40 mM 120"13 6, 1 exp.
 .  .Quinidine 10 mM 100 mM 91" 4 6, 1 exp.
 .  .Tamoxifen 10–50 mM 50 mM 25"26 12
 .  .Progesterone 25 mM 50 mM 37" 9 6
 .100 mM -9 6
The modifiers were present during the last 30 min of iodide loading and throughout the subsequent efflux period. Efflux was stimulated
by changing from isotonic solution containing 90 mM mannitol to hypotonic solution in which the mannitol had been omitted. Responses
with and without the agents are compared at the peak increase in rate constant for efflux. None means that no increase in efflux could be
seen the presence of the modifier. The concentrations given in brackets for each drug have previously been shown to inhibit
w xP-glycoprotein-mediated efflux activity and to produce a threefold increase in intracellular vincristine accumulation 7 .
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methacin nor piroxicam at 100 mM altered the rate of
efflux which indicates that products of cyclooxy-
genase are not essential for the hypotonicity-induced
efflux. By contrast the 5-lipoxygenase inhibitors
ETH615 and L-656,224 at 10 mM produced nearly
total block, strongly suggesting a role for leuko-
trienes.
The effects of several different substrates and in-
hibitors of P-glycoprotein on the iodide efflux from
brain endothelial cells were investigated see Table
.2 . Verapamil, which blocks drug efflux by P-glyco-
w xprotein at 10 mM 7 , did not produce clear inhibition
of iodide efflux at concentrations below 50 mM. At
100 mM, verapamil reduced the initial amount loaded
into the cells in each well about fivefold and elimi-
 .nated stimulated release. Quinidine 100 mM ,
 .  .forskolin 40 mM , 1,9-dideoxyforskolin 40 mM ,
 .and cyclosporin A 10 mM at concentrations that are
w xknown to block drug efflux 7 , produced no reduc-
tion in iodide efflux. Treatment with both tamoxifen
 .  .50 mM and progesterone 50 and 100 mM pro-
duced substantial block.
4. Discussion
Mechanisms for regulatory volume increase gener-
w xally involve uptake of ions by cotransporters 12–14
followed more slowly, at least in some cell types, by
w xuptake of organic osmolytes 3 . Regulatory volume
decreases in epithelial and endothelial cells occur
primarily by loss of K and Cl ions via channels
though in some cell types loss of organic solutes is
w xalso significant 3,15 . Many of the studies investigat-
ing ionic movements have used whole cell patch
clamp recordings. In the present work, we have used
the iodide efflux technique to monitor anion perme-
ability in populations of cells, thus obtaining popula-
tion averages and eliminating any problems of in-
terindividual cell variations.
From these measurements we have been able to
show the presence of anion permeability increases
following hypotonic challenge in endothelial cells
derived from rat brain microvessels. The increases
could be detected with osmolality changes as small as
30 mOsmol and depend on the level of hypotonicity.
In endothelial cells grown from the rat aorta, the
permeability increases were much smaller, suggesting
that this type of endothelial cell may not respond so
readily to volume changes.
Volume regulatory responses have been investi-
w xgated in a number of endothelial cell types 4 . In
vascular endothelium, regulation of cell volume is
thought to be important in maintaining barrier func-
w xtion 12 . This may be particularly relevant in the
case of the blood–brain barrier as large fluxes of
polar solutes must pass through these cells which
exposes them to the risk of large changes in cell
solute content and in cell volume. Thus endothelial
cells derived from brain microvessels may require
more highly developed systems for regulation of their
cell volume than endothelial cells from other parts of
the vasculature. Hence their ready response following
relatively small changes in osmolality.
We have also investigated the properties of this
anion efflux pathway in the rat brain endothelial
cells. It shows similarities with but also differences
from volume-activated chloride channels described in
other types of cell. Specifically there are differences
in the effects of the chloride channel blockers, DIDS
and NPPB. These agents have been shown to block
swelling-activated chloride currents in various cell
types including primary cultures of human astrocy-
w xtoma cells 16 , and some endothelial cell types, e.g.,
w xthose derived from human umbilical vein 17,18 , in
this case, DIDS showing half maximal inhibition at
120 mM. With rat brain endothelial cells NPPB at
100 mM blocked the permeability increase, but DIDS
had little if any effect. DPC at 100 mM was likewise
without effect.
The effect of DIDS on swelling-induced chloride
ion movements in brain endothelial cells have already
been studied using whole cell patch clamp recordings
w x10 . In these experiments, it was shown that DIDS at
100 mM could suppress outward current representing
inward movement of chloride. However, it was not
able to reduce the inward current representing out-
ward movement of chloride ions. These earlier obser-
vations are thus consistent with a lack of effect of
DIDS in the iodide efflux studies, since the resting
potential of these cells is expected to be negative
relative to the reversal potential for the chloride
channels.
In line with what has been observed in human
w xumbilical vein endothelial cells 19 , the response in
the rat brain endothelial cells is dependent on ATP
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levels, reduction of intracellular ATP abolishing the
response.
A number of different intracellular pathways may
mediate these hypotonicity induced changes in anion
permeability and different ones have been implicated
in different cell types. In some cells such as human
w xfibroblasts 20 , the responses depend on extracellular
and intracellular calcium. By contrast, in the present
study, removal of external calcium had no noticeable
effect on the response seen in the rat brain endothe-
lium and a deliberate increase in intracellular calcium
induced by A23187 did not provoke a permeability
increase. Nevertheless, the response does seem to
require the presence of calcium. In some experi-
ments, depletion of internal stores using thapsigargin
 .1 mM and removal of external calcium together
brought about a reduction in response. This thapsigar-
gin effect was somewhat variable, a phenomenon
possibly accounted for by the presence of P-glyco-
w xprotein in the cells 7 . It has been shown previously
that expression of P-glycoprotein is one of the fac-
w xtors leading to resistance to thapsigargin 21 . Further
evidence that calcium is important in the responses
was obtained by using a higher concentration of
thapsigargin, by employing an alternative inhibitor,
dtBHQ, and by depletion of internal calcium using
A23187. The higher concentration of thapsigargin
abolished the response while dtBHQ and A23187
with external EGTA both substantially reduced it.
These observations can be explained if a low concen-
tration of calcium within the cell is required for a
response to occur, but an increase in calcium is not
the trigger for the response, an idea proposed by
w xSzucs et al 22 . Quite possibly, enzymes involved in¨
the response pathway may require calcium, but only
at or somewhat below the levels normally present
within the cell.
In support of this idea, it was observed that the
calmodulin inhibitor, pimozide, and inhibitors of the
calcium-requiring enzymes, phospholipase A and2
5-lipoxygenase, reduced or blocked the response.
Such observations suggest an important role for
leukotrienes generated in response to activation of
phospholipase A . These effects are reminiscent of2
w xthe responses observed in fibroblasts 20 and Ehrlich
w xascites tumour cells 23 . By contrast, cyclooxy-
genase inhibitors failed to produce any significant
effect. These effects differ from those observed in
endothelial cells derived from human umbilical vein
w x17 , where phospholipase blockade but not lipooxy-
genase inhibition reduced the responses.
Other differences between different endothelial cell
types concern the effects of agents that modulate
P-glycoprotein function. Certain P-glycoprotein
modulators, e.g., tamoxifen, progesterone and vera-
pamil were found to have effects on the anion perme-
ability changes observed in the rat brain endothelial
cells, though in the case of verapamil, this was at a
concentration substantially higher than that shown to
w xinhibit P-glycoprotein activity 7 . However, other
agents, i.e., dideoxyforskolin, cyclosporin A used at
concentrations known to block drug efflux activity in
w xthese cells 7 were without effect on the hypotonic-
ity-induced increases in anion efflux. This is in con-
trast to the results seen by others in other endothelial
w xcell types where both dideoxyforskolin 17 and cy-
w xclosporin A 18 were able to inhibit the responses,
albeit at concentrations 60 mM and 10 mM, respec-
.tively slightly higher than those used in the present
 .study 40 mM and 2 mM, respectively .
Opinion is still very much divided on the influence
that P-glycoprotein may have on swelling-activated
chloride channels. The basis of this dispute may lie in
the existence of different types of these chloride
channels in the different cells that have been studied.
Whether or not P-glycoprotein is involved in regulat-
ing or modifying the activity of the channels present
in the rat brain endothelial cells is not known. We
have already demonstrated from RT-PCR and West-
ern blot analysis that both mdr1a and to a greater
extent mdr1b P-glycoprotein is expressed in these
cells in primary culture and that this P-glycoprotein
w xis functionally active 7 . It remains to determined
therefore if the function of the swelling-activated
channels is in any way impaired when P-glyco-
protein expression is transiently ablated by antisense
oligonucleotide treatment. These studies are currently
in progress.
It seems therefore that in the rat brain endothelial
cells, the characteristics of the chloride channels acti-
vated by swelling and the pathways involved in
regulating these channels may be different from those
observed by others in other endothelial cell types
w x4,17,18 . This is not surprising, considering the dif-
ferent roles played by the endothelium in different
situations. It has been suggested that different chan-
( )S.F. ˝on Weikersthal et al.rBiochimica et Biophysica Acta 1325 1997 99–107 107
nel proteins may be responsible for anion movements
in different cell types and that more than one type of
anion-selective channel could play a role in volume
w xregulation 24,25 . Whether therefore brain endothe-
lial cells contain channels different from those in
other endothelial cell types or whether they contain
the same channels that are expressed in a different
regulatory environment is not yet clear. Answers to
this question will require further identification of the
channels expressed in these cells both at the phar-
macological and the molecular level. Such studies are
already being undertaken by others to identify the
chloride channels in endothelial cells of bovine pul-
w xmonary artery 26 . Since it is likely that factors
within the brain may influence events in endothelial
cells derived from the blood–brain barrier, further
studies of volume regulation in brain endothelial cells
following co-culture with astrocytes could prove very
informative.
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